Teva Pharmaceuticals has a long and impressive history of corporate social responsibility, and is the world’s largest provider by volume of in-kind pharmaceutical donations. Direct Relief has worked closely with Teva and is one of its few trusted partners globally, as well as Teva’s only Rx partner for Rx donations to benefit safety net providers within the United States. Direct Relief has also been the recipient of numerous financial grants from Teva to support joint multiple chronic conditions programming within the United States.
Jointly Teva and Direct Relief have been awarded important industry recognitions including the Eyeforpharma’s Most Important Collaboration award, the WEGO Health Patient Choice award, and the Pharma Intelligence award. Teva has generously donated Rx medicines valued at over $1 billion (wholesale) that has helped millions of underserved patients across all 50 states, Puerto Rico and other US territories, and over 80 countries around the world.
Teva has also been a huge contributor of Rx medicines to Direct Relief’s disaster and emergency responses over the years, including for the COVID-19 global pandemic which has devasted communities across the world.
Teva supports Direct Relief through key initiatives aimed at addressing a specific population or area of need.
The Enhancing Access2Care initiative is funded by Teva and implemented together with Direct Relief and Volunteers in Medicine. The program provides award funding to Volunteers in Medicine Clinics to support innovative approaches in the care and treatment of patients with multiple chronic conditions. Learn more